Umer Raffat
Stock Analyst at Evercore ISI
(4.11)
# 1,632
Out of 4,994 analysts
163
Total ratings
52.1%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | n/a | $39.52 | - | 10 | Sep 2, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | n/a | $25.51 | - | 1 | Aug 25, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Hold | n/a | $1,170.14 | - | 14 | Aug 6, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | n/a | $152.67 | - | 16 | Aug 5, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | n/a | $38.17 | - | 1 | Jul 6, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | n/a | $91.97 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | n/a | $59.02 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $225.36 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $12.79 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $22.93 | - | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $410.24 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.17 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.93 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.70 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.80 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.64 | +77.30% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $58.52 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.29 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.40 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.87 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.553 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.00 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.99 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $150.91 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $17.32 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.00 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $7.76 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $18.64 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.18 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $240.57 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $158.13 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.12 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $22.12 | n/a | 1 | Mar 9, 2018 |
Teva Pharmaceutical Industries
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.52
Upside: -
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $25.51
Upside: -
Eli Lilly and Company
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,170.14
Upside: -
Gilead Sciences
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $152.67
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $38.17
Upside: -
Spyre Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $91.97
Upside: -
Vaxcyte
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $59.02
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $225.36
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $12.79
Upside: -
Elanco Animal Health
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.93
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $410.24
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.17
Upside: -
Apr 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.93
Upside: -
Apr 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.70
Upside: -
Mar 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.80
Upside: -
Mar 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.64
Upside: +77.30%
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $58.52
Upside: -
Nov 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $43.29
Upside: -
Nov 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.40
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $26.87
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.553
Upside: -
May 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $22.00
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.99
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $150.91
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $17.32
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $33.00
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $7.76
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $18.64
Upside: n/a
Dec 9, 2021
Reiterated: Buy
Price Target: n/a
Current: $17.18
Upside: n/a
Jan 28, 2021
Reiterated: Buy
Price Target: n/a
Current: $240.57
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $158.13
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: n/a
Current: $4.12
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $22.12
Upside: n/a